Kelli Wuerth

Providence Health Care — Canada

Immunology and Microbiology · Life Sciences

10h-index985citations27works3.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Antimicrobial Peptides and Activities(10), Hepatitis C virus research(5), Immune Response and Inflammation(4), COVID-19 and Mental Health(3), Mental Health and Patient Involvement(3)

Publications27 total

Understanding the Characteristics of a Large Cohort of Youths Accessing In-Person and Virtual Peer Support Services
Psychiatric Services·2026
Implementing a learning health system within an integrated youth service initiative -a real-world case study.
International Journal of Integrated Care·2025Open Access
Service providers’ perspectives on youth peer support: the importance of integration and oversight – an interpretive description study in British Columbia, Canada
BMJ Open·2025· 2 citedOpen Access
Foundry, the British Columbia Integrated Youth Services Initiative: Sharing Lessons From a Decade of Innovation
Healthcare Quarterly·2025
Supporting young people through the COVID-19 pandemic and beyond: a multi-site qualitative longitudinal study
BMC Health Services Research·2024· 2 citedOpen Access
Implementing Foundry: A cohort study describing the regional and virtual expansion of a youth integrated service in British Columbia, Canada
Early Intervention in Psychiatry·2024· 15 citedOpen Access
Supporting young people through the COVID-19 pandemic and beyond: A multi-site qualitative longitudinal study
2023Open Access
Understanding Mobile Health and Youth Mental Health: Scoping Review
JMIR mhealth and uhealth·2023· 29 citedOpen Access
Understanding Mobile Health and Youth Mental Health: Scoping Review (Preprint)
2022Open Access
Substance Use and Co-occurring Infections (Including Immunology)
2020
Overdose events among active drug users successfully treated for HCV: the impact of homelessness
Journal of Hepatology·2020Open Access
Glecaprevir/pibrentasvir for the treatment of hepatitis C virus infection among active drug users: the grand plan study
Journal of Hepatology·2020Open Access
COVID-19 in Homeless Populations: Unique Challenges and Opportunities
Future Virology·2020· 36 citedOpen Access
Putting a Roof Over people’s Heads: an Important Part of Addressing Hcv Infection Among People Who Inject Drugs
Future Virology·2020· 1 cited
381 TREATMENT OF HCV INFECTION AMONG PEOPLE WHO USE DRUGS (PWUD): A LONGITUDINAL REAL-LIFE COHORT
Gastroenterology·2020
Sofosbuvir and Velpatasvir in the Treatment of Chronic Hepatitis C
Future Virology·2019· 1 cited
Characterization of Host Responses during Pseudomonas aeruginosa Acute Infection in the Lungs and Blood and after Treatment with the Synthetic Immunomodulatory Peptide IDR-1002
Infection and Immunity·2018· 20 citedOpen Access
Identification of an IDR peptide formulation candidate that prevents peptide aggregation and retains immunomodulatory activity
Peptide Science·2018· 13 cited
Synthetic host defense peptide IDR-1002 reduces inflammation in Pseudomonas aeruginosa lung infection
PLoS ONE·2017· 35 citedOpen Access
New Mouse Model for Chronic Infections by Gram-Negative Bacteria Enabling the Study of Anti-Infective Efficacy and Host-Microbe Interactions
mBio·2017· 143 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Robert E. W. Hancock(10), Skye Barbic(9), Brian Conway(5), Tianna Magel(5), David Truong(4), Steve Mathias(4), Ashley L. Hilchie(3), Xiaoxu Ding(3), Karen Tee(3), Lauren Jones(3), Negin Rahanjam(2), Reza Falsafi(2), Brodie M. Sakakibara(2), Julia Schmidt(2), Natalie Parde(2), Liisa Holsti(2), Emilie Mallia(2), Madelyn Whyte(2), Emily Nichol(2), Lisa D. Hawke(2)